Select Medical Holdings Corporation
Price Action
Technical Summary
STAGE 2 UPTRENDSelect Medical Holdings Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 71), indicating performance broadly in line with the market. Earnings contraction of 18% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.42 | +0.07% | ABOVE |
| 50 SMA | $16.23 | +1.25% | ABOVE |
| 100 SMA | $15.75 | +4.29% | ABOVE |
| 150 SMA | $15.13 | +8.61% | ABOVE |
| 200 SMA | $14.58 | +12.72% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SEM in an uptrend right now?
SEM has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, SEM is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is SEM overbought or oversold?
SEM's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is SEM outperforming the market?
SEM has a Relative Strength (RS) Rating of 71 out of 99. SEM is performing about average compared to the market.
Where is SEM in its 52-week range?
SEM is trading at $16.43, which is 97% of its 52-week high ($16.99) and 90% above its 52-week low ($11.65).
How volatile is SEM?
SEM has a Beta of 0.46 and 52-week volatility of 39%. It's less volatile than the S&P 500 - generally more stable.